Summary
Updated Aug 30, 2026
Rekha Hemrajani files SEC Form 4 reports at MAXCYTE, INC. (MXCT). 8 SEC Form 4 filings on record going back to 2024, most recently on 22 June 2026. Most recent open-market trade: sold $22K of MXCT on 25 June 2025. Lifetime open-market purchases: $46K. Lifetime open-market sales: $22K.
Recent Transactions
4Every recent SEC Form 4 transaction Rekha Hemrajani has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Rekha Hemrajani files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Deep Track Biotechnology Master Fund, Ltd. - $60.00M of LBRX open-market activity in the last 12 months
- Pontifax Management 4 G.P. (2015) Ltd. - $15.00M of LBRX open-market activity in the last 12 months
- Ran Nussbaum - $15.00M of LBRX open-market activity in the last 12 months
- Vida Ventures GP III, L.L.C. - $5.00M of LBRX open-market activity in the last 12 months
- Kristen Fortney - $4.22M of BIOA open-market activity in the last 12 months
- Shane Barton - $1.58M of BIOA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Rekha Hemrajani?
Rekha Hemrajani is a corporate insider of MAXCYTE, INC. (MXCT). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Rekha Hemrajani submitted recently?
3 primary Form 4 filings in the last 90 days, covering 3 companies.
Has Rekha Hemrajani been buying or selling stock?
Recorded transactions: 1 open-market purchase ($46K) and 1 open-market sale ($22K) across all tracked filings.
Where can I see all of Rekha Hemrajani's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Rekha Hemrajani and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
